Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
FDA-Approved Clinical Indications Primary Indication Management of Resistant Anemia and Muscle Cramps: Specifically indicated for the treatment of carnitine deficiency in dialysis patients to improve the response to Erythropoiesis-Stimulating Agents (ESAs) in cases of resistant anemia and to reduce the frequency and severity of intradialytic skeletal muscle cramps
daily for 14 days using a 1-mL syringe and a 23-gauge needle
70 , 516S524S (1999)
May support fat utilization during physical activity
Benzodiazepines Benzodiazepines like clonazepam (Klonopin) and alprazolam (Xanax) promote sleep and relieve anxiety
US$ 20.40
US$ 29.42
US$ 29.16
US$ 28.78
